Corporate Board Profile
Tech Score: 13/100
1 mention(s) identify RAMKUMAR MANDALAM, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Cryoport, Inc. | 2014-07-25 | Mr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Mr. Mandalam is the author or co-author of several publications, patent applications, and abstracts. | Holds a Ph.D. in Chemical Engineering and has extensive experience in biotechnology product development, indicating technical expertise likely including programming or related skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2014-07-25 | Mr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Mr. Mandalam is the author or co-author of several publications, patent applications, and abstracts. |
| 2015-10-01 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. |
| 2019-04-03 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan. His background is in biotechnology and management of cell-based therapies. |
| 2020-04-03 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. |
| 2021-03-16 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Dr. Mandalam’s training as a scientist, extensive background in biotechnology and management expertise and makes him well-qualified to serve as a member of the board of directors. |
| 2022-03-18 | Dr. Mandalam has a Ph.D. in Chemical Engineering and extensive biotechnology experience but no mention of programming or software engineering skills. |
| 2023-03-31 | Dr. Mandalam is currently the Founder and CEO of Citra BioConsulting Inc., a cell therapy and biologics development consulting firm. Prior to founding Citra BioConsulting in 2021, he was the CEO, President and board member of Cellerant Therapeutics, Inc., a clinical stage biotechnology company developing novel cell-based and antibody therapies for cancer treatment and blood-related disorders. Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. |
| 2024-04-03 | Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. He has extensive background in biotechnology and management expertise. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22